vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and EVERSPIN TECHNOLOGIES INC. (MRAM). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $14.9M, roughly 1.5× EVERSPIN TECHNOLOGIES INC.). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -2.0%, a 48.3% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs 13.2%). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs 18.2%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
Everspin Technologies, Inc. is a publicly traded semiconductor company headquartered in Chandler, Arizona, United States. It develops and manufactures discrete magnetoresistive RAM or magnetoresistive random-access memory (MRAM) products, including Toggle MRAM and Spin-Transfer Torque MRAM (STT-MRAM) product families. It also licenses its technology for use in embedded MRAM (eMRAM) applications, magnetic sensor applications as well as performs backend foundry services for eMRAM.
GCBC vs MRAM — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $14.9M |
| Net Profit | $10.3M | $-296.0K |
| Gross Margin | — | 52.7% |
| Operating Margin | 52.0% | 29.0% |
| Net Margin | 46.3% | -2.0% |
| Revenue YoY | 23.8% | 13.2% |
| Net Profit YoY | 37.4% | — |
| EPS (diluted) | $0.60 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $14.9M | ||
| Q4 25 | $22.2M | $14.8M | ||
| Q3 25 | $21.5M | $14.1M | ||
| Q2 25 | $20.5M | $13.2M | ||
| Q1 25 | $20.1M | $13.1M | ||
| Q4 24 | $17.9M | $13.2M | ||
| Q3 24 | $16.9M | $12.1M | ||
| Q2 24 | $16.6M | $10.6M |
| Q1 26 | — | $-296.0K | ||
| Q4 25 | $10.3M | $1.2M | ||
| Q3 25 | $8.9M | $54.0K | ||
| Q2 25 | $9.3M | $-670.0K | ||
| Q1 25 | $8.1M | $-1.2M | ||
| Q4 24 | $7.5M | $1.2M | ||
| Q3 24 | $6.3M | $2.3M | ||
| Q2 24 | $6.7M | $-2.5M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | — | 50.8% | ||
| Q3 25 | — | 51.3% | ||
| Q2 25 | — | 51.3% | ||
| Q1 25 | — | 51.4% | ||
| Q4 24 | — | 51.3% | ||
| Q3 24 | — | 49.2% | ||
| Q2 24 | — | 49.0% |
| Q1 26 | — | 29.0% | ||
| Q4 25 | 52.0% | -7.2% | ||
| Q3 25 | 47.4% | -11.0% | ||
| Q2 25 | 53.5% | -14.9% | ||
| Q1 25 | 44.6% | -14.7% | ||
| Q4 24 | 45.0% | -11.8% | ||
| Q3 24 | 39.6% | -17.5% | ||
| Q2 24 | 41.2% | -26.5% |
| Q1 26 | — | -2.0% | ||
| Q4 25 | 46.3% | 8.1% | ||
| Q3 25 | 41.2% | 0.4% | ||
| Q2 25 | 45.6% | -5.1% | ||
| Q1 25 | 40.1% | -8.9% | ||
| Q4 24 | 41.7% | 9.2% | ||
| Q3 24 | 37.1% | 18.8% | ||
| Q2 24 | 40.6% | -23.5% |
| Q1 26 | — | $-0.01 | ||
| Q4 25 | $0.60 | $0.05 | ||
| Q3 25 | $0.52 | $0.00 | ||
| Q2 25 | $0.55 | $-0.03 | ||
| Q1 25 | $0.47 | $-0.05 | ||
| Q4 24 | $0.44 | $0.07 | ||
| Q3 24 | $0.37 | $0.10 | ||
| Q2 24 | $0.39 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $258.3M | $70.2M |
| Total Assets | $3.1B | $83.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $40.5M | ||
| Q4 25 | — | $44.5M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | — | $45.0M | ||
| Q1 25 | $155.5M | $42.2M | ||
| Q4 24 | $166.4M | $42.1M | ||
| Q3 24 | — | $39.6M | ||
| Q2 24 | $190.4M | $36.8M |
| Q1 26 | — | $70.2M | ||
| Q4 25 | $258.3M | $68.9M | ||
| Q3 25 | $248.2M | $65.8M | ||
| Q2 25 | $238.8M | $64.1M | ||
| Q1 25 | $229.0M | $63.0M | ||
| Q4 24 | $218.4M | $62.6M | ||
| Q3 24 | $216.3M | $59.3M | ||
| Q2 24 | $206.0M | $55.4M |
| Q1 26 | — | $83.2M | ||
| Q4 25 | $3.1B | $84.6M | ||
| Q3 25 | $3.1B | $80.3M | ||
| Q2 25 | $3.0B | $78.9M | ||
| Q1 25 | $3.0B | $80.2M | ||
| Q4 24 | $3.0B | $77.8M | ||
| Q3 24 | $2.9B | $72.6M | ||
| Q2 24 | $2.8B | $64.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $570.0K |
| Free Cash FlowOCF − Capex | $6.2M | — |
| FCF MarginFCF / Revenue | 28.0% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $570.0K | ||
| Q4 25 | $6.4M | $2.6M | ||
| Q3 25 | $7.0M | $881.0K | ||
| Q2 25 | $28.0M | $5.0M | ||
| Q1 25 | $7.3M | $1.4M | ||
| Q4 24 | $5.3M | $3.8M | ||
| Q3 24 | $2.1M | $2.8M | ||
| Q2 24 | $24.9M | $1.7M |
| Q1 26 | — | — | ||
| Q4 25 | $6.2M | $-975.0K | ||
| Q3 25 | $6.5M | $543.0K | ||
| Q2 25 | $27.3M | $3.0M | ||
| Q1 25 | $7.3M | $527.0K | ||
| Q4 24 | $5.1M | $2.1M | ||
| Q3 24 | $2.0M | $2.8M | ||
| Q2 24 | $23.4M | $1.7M |
| Q1 26 | — | — | ||
| Q4 25 | 28.0% | -6.6% | ||
| Q3 25 | 30.4% | 3.9% | ||
| Q2 25 | 133.3% | 22.9% | ||
| Q1 25 | 36.1% | 4.0% | ||
| Q4 24 | 28.6% | 15.8% | ||
| Q3 24 | 11.8% | 22.9% | ||
| Q2 24 | 141.2% | 15.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 24.3% | ||
| Q3 25 | 1.9% | 2.4% | ||
| Q2 25 | 3.4% | 15.1% | ||
| Q1 25 | 0.3% | 6.9% | ||
| Q4 24 | 1.0% | 13.2% | ||
| Q3 24 | 0.9% | 0.5% | ||
| Q2 24 | 9.1% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.62× | 2.19× | ||
| Q3 25 | 0.78× | 16.31× | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | 3.16× | ||
| Q3 24 | 0.34× | 1.25× | ||
| Q2 24 | 3.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCBC
Segment breakdown not available.
MRAM
| Product sales | $14.1M | 95% |
| Licensing, royalty, patent, engineering services and other revenue | $772.0K | 5% |
